Surgery Websites
Transplant Surgery »  Meet the Team »  Transplant Surgeons »  Peter G. Stock, M.D., Ph.D.

Peter G. Stock, M.D., Ph.D.

Professor of Surgery
Surgical Director, Kidney and Pancreas Transplant Program
Surgical Director, Pediatric Renal Transplant Program
Co-Director, Pancreatic Islet Cell Transplant Program
Program, Director, T32 Training Program in Transplant Surgery

Contact Information

Academic Office
(415) 353-8617
Open Popup
  • University of Illinois, Urbana, IL, B.S., Biology, 1974-78
  • University of Illinois, Chicago, IL, M.D., Medicine, 1978-82
  • University of Minnesota, Minneapolis, MN, Ph.D., Surgery, 1985-92
  • University of Minnesota, Intern, General Surgery, 1982-83
  • University of Minnesota, Resident, General Surgery, 1983-90
  • University of California, San Francisco, Fellow, Transplant Surgery, 1990-92
  • American Board of Surgery, 1991
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Choledochal Cyst Disease
  • Dialysis Access
  • End-Stage Kidney Disease
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Kidney and LIver Transplantation in HIV Patients
  • Kidney Transplantation
  • Liver Transplantation
  • Living Donor Kidney Transplantation
  • Living Donor Liver Transplantation
  • Pancreas Transplantation
  • Pancreatic Islet Cell Transplantation
  • Pediatric Kidney Transplantation
  • Pediatric Liver Transplantation
  • Polycystic Kidney Disease
  • Polycystic Liver Disease
  • Portal Hypertension
  • Induction of transplantation tolerance to block alloimmunity and recurrent autoimmunity following pancreatic islet transplantation
  • Safety and efficacy of solid organ transplantation in people with HIV

Peter G. Stock, M.D., Ph.D. is Professor of Surgery at UCSF, Surgical Director of the Pediatric Renal Transplantation Program and Surgical Director of the Pancreas Transplant Program. He was trained at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992. Dr. Stock specializes in liver, kidney and pancreas transplantation.

For many years, Dr. Stock was Chair of the Department of Surgery Research Committee. Under his  outstanding leadership. he has helped to establish UCSF Surgery as one of the top research programs for surgical residents in the U.S.

clincial investigation on which Dr. Stock served as principal investigator led the passage of the Hope Act lifting the ban on research for transplanting organs between HIV-positive donors and recipients.

Dr. Stock is a frequent presenter on issues related to transplantation and immunosuppression, and holds membership in numerous professional and honorary societies.

  Confired By    
  • James IVth Fellowship Award
  • US Representative
  • 2000
  • Faculty Fellowship Award
  • American College of Surgeons
  • 1993
  • Sandoz Fellowship Award
  • American Society of Transplant Surgeons
  • 1991
  • Outstanding Surgical Resident Teaching Award
  • Department of Surgery, University of Minnesota, Minneapolis, MN
  • 1989
  • David Gaviser Award, Outstanding Surgical Research
  • University of Minnesota, Minneapolis, MN
  • 1989
  • Outstanding Research Award, Senior Medical Student
  • University of Illinois, Chicago, IL
  • 1982
  • Alpha Omega Alpha
  • University of Illinois, Chicago, IL
  • 1981
  • Magna Cum Laude, Honors in Biology with High Distinction
  • University of Illinois, Urbana, IL
  • 1978
  • Phi Beta Kappa
  • University of Illinois, Urbana, IL
  • 1978
  • Pancreatic Islet Transplantation
    The translational research in the field of pancreatic islets revolves around clinical trials of the safety and efficacy of islet transplantation in patients with Type I diabetes. The clinical trials are funded by the National Institutes of Health (NIH) and the Juvenile Diabetes Research Foundation (JDRF). These clinical trials focus on novel immunosuppressive strategies that utilize co-stimulatory blockade to prevent the immune response against pancreatic islets with a regimen that is not toxic to kidneys or beta cells.

    Related research involves improving the techniques required for isolating pancreatic islets from the pancreas, which is being conducted in a fully compliant GMP laboratory facility. The study of the alloimmune and autoimmune response following islet transplantation will be conducted to determine the efficacy of the immunosuppressive strategies. Further translational studies will include methods of expanding the source of beta cells, using direct proliferation, as well as manipulation of precursor cells localized in the adult pancreas. We are currently funded (PI) for a translational grant from California Institute of Regenerative Medicine (CIRM) to bring embryonic stem cell-derived beta cells to a clinical trial.

    Solid Organ Transplantation in People with HIV
    With the advent of highly active anti-retroviral therapy (HAART), HIV has been a chronic disease. People with HIV are no longer dying from progression of HIV to AIDS, but rather as a result of end stage live disease (viral hepatitis co-infection) and kidney disease (HIV nephropathy). Our laboratory heads up the large NIH-sponsored national multicenter trial which is studying the safety and efficacy of solid organ transplantation in people with HIV. Translational research is exploring the impact of HIV on organ function and the impact of immunosuppression on the immune response against HIV and associated copathogens.

    Data provided by UCSF Profiles, powered by CTSI
    • Filling a Void of Research (FAVOR) Training for Transplant Surgeons
      Sponsor ID:
      Funding Period:
      Aug 2016
      Jul 2021
      Principal Investigator
    • Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
      Sponsor ID:
      Funding Period:
      Aug 2015
      Jul 2020
      Principal Investigator
    • Diabetes Research Center
      Sponsor ID:
      Funding Period:
      Sep 2002
      Mar 2020
    • Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant
      Sponsor ID:
      Funding Period:
      Jan 2015
      Dec 2017
      Principal Investigator
    • Solid Organ Transplantation in HIV: Multi-Site Study
      Sponsor ID:
      Funding Period:
      Aug 2003
      Aug 2013
      Principal Investigator
    • General Clinical Research Center
      Sponsor ID:
      Funding Period:
      Dec 1974
      Mar 2009
    Data provided by UCSF Profiles, powered by CTSI
    Data provided by UCSF Profiles, powered by CTSI
    1. Kates OS, Stock PG, Ison MG, Allen RDM, Burra P, Jeong JC, Kute V, Muller E, Nino-Murcia A, Wang H, Wall A. Ethical review of COVID-19 vaccination requirements for transplant center staff and patients. Am J Transplant. 2021 Oct 27. View in PubMed
    2. Braun HJ, Amara D, Shui AM, Stock PG, Hirose R, Delmonico FL, Ascher NL. International Travel for Liver Transplantation: A Comprehensive Assessment of the Impact on the United States Transplant System. Transplantation. 2021 Oct 04. View in PubMed
    3. Werbel WA, Brown DM, Kusemiju OT, Doby BL, Seaman SM, Redd AD, Eby Y, Fernandez RE, Desai NM, Miller J, Bismut GA, Kirby CS, Schmidt HA, Clarke WA, Seisa M, Petropoulos CJ, Quinn TC, Florman SS, Huprikar S, Rana MM, Friedman-Moraco RJ, Mehta AK, Stock PG, Price JC, Stosor V, Mehta SG, Gilbert AJ, Elias N, Morris MI, Mehta SA, Small CB, Haidar G, Malinis M, Husson JS, Pereira MR, Gupta G, Hand J, Kirchner VA, Agarwal A, Aslam S, Blumberg EA, Wolfe CR, Myer K, Wood RP, Neidlinger N, Strell S, Shuck M, Wilkins H, Wadsworth M, Motter JD, Odim J, Segev DL, Durand CM, Tobian AAR, HOPE in Action Investigators . National Landscape of HIV+ Deceased Organ Donors in the United States. Clin Infect Dis. 2021 Aug 28. View in PubMed
    4. Stock PG, Lentine KL. Maximizing the use of hard to place kidneys: Getting the right kidney to the right recipient at the right time. Am J Transplant. 2021 Jul 30. View in PubMed
    5. Boggi U, Vistoli F, Andres A, Arbogast HP, Badet L, Baronti W, Bartlett ST, Benedetti E, Branchereau J, Burke GW, Buron F, Caldara R, Cardillo M, Casanova D, Cipriani F, Cooper M, Cupisti A, Davide J, Drachenberg C, de Koning EJP, Ettorre GM, Fernandez Cruz L, Fridell JA, Friend PJ, Furian L, Gaber OA, Gruessner AC, Gruessner RWG, Gunton JE, Han DJ, Iacopi S, Kauffmann EF, Kaufman D, Kenmochi T, Khambalia HA, Lai Q, Langer RM, Maffi P, Marselli L, Menichetti F, Miccoli M, Mittal S, Morelon E, Napoli N, Neri F, Oberholzer J, Odorico JS, Öllinger R, Oniscu G, Orlando G, Ortenzi M, Perosa M, Perrone VG, Pleass H, Redfield RR, Ricci C, Rigotti P, Paul Robertson R, Ross LF, Rossi M, Saudek F, Scalea JR, Schenker P, Secchi A, Socci C, Sousa Silva D, Squifflet JP, Stock PG, Stratta RJ, Terrenzio C, Uva P, Watson CJE, White SA, Marchetti P, Kandaswamy R, Berney T. First World Consensus Conference on pancreas transplantation: Part II - recommendations. Am J Transplant. 2021 Sep; 21 Suppl 3:17-59. View in PubMed
    6. View All Publications


    Site Directory